Cover more ground
Investigate more assets, markets, and questions with research agents and connected evidence. Apply your screening method across more opportunities before choosing candidates for deeper diligence.
We’re building the live intelligence era.
Maven Bio brings live intelligence to biopharma, consulting, and investment teams. Investigate more opportunities, see what changes your position, and make strategic decisions with current evidence.
Move from static research to live intelligence.
New evidence can change a strategy, opportunity screen, or forecast between reviews. A clinical result can alter a differentiation claim. A competitor’s development can change an asset’s appeal. A local funding decision can narrow the population behind a market estimate.
With live intelligence, your team can investigate those changes as they emerge and carry the findings into its ongoing work.
Spend less time catching up
Follow the developments that matter to your team and keep selected working files current with source-linked edits. Start the next review with the changes and their supporting evidence available to inspect.
Make more room for judgment
Review what changed and the supporting evidence, then focus on implications, tradeoffs, and next steps. Your team can challenge assumptions and decide what the findings mean for a strategy, recommendation, or investment thesis.
Live intelligence built around your team’s decisions.
A connected view of biopharma
Maven follows clinical, regulatory, company, and market-access developments across global sources. It connects findings to drugs, companies, trials, and markets so your team can assess an opportunity with evidence from beyond the sources it can follow by hand.
Changes assessed against your priorities
Define the assets, markets, questions, and assumptions that matter to your team. Maven assesses new evidence against that scope and explains why a finding affects your work. Bring your internal context and research criteria into the assessment.
Research that carries forward
Use the findings in your assessments, briefings, and forecasts. Maven can apply source-linked edits to selected project files and reuse your research methods for recurring work. Inspect the evidence, review the revisions, and download the current files when you need them.
How teams put Maven to work.
Start with a research question, an asset screen, or a document review. Use the Research Agent to investigate an opportunity, Smart Tables to compare assets, and Document Grids to examine their supporting evidence.
Add monitoring to follow material changes between reviews. Save your team’s questions, criteria, and deliverable format as a workflow for recurring research. For maintained files, review sourced edits, roll back changes, and download Word, Excel, or PowerPoint files from your Maven project.
Work in Maven or connect its intelligence to a compatible AI assistant. Teams can also query structured data and retrieve monitoring findings through the API, with webhook notifications when new signals are available.
Who uses Maven
Pharma and biotech teams
Support medical affairs, business development, competitive intelligence, portfolio strategy, market access, and forecasting with current evidence and maintained working files.
For biopharma teamsLife sciences consultants
Research client questions using your firm’s methods, and keep client working files current between readouts.
For consultantsInvestment firms
Investigate opportunities and keep selected diligence files current as clinical, competitive, and access developments challenge your thesis.
For investment teamsCompany logos
The company behind the work
Building since 2023
Maven grew out of firsthand experience with the time and effort it takes to evaluate a company or therapeutic opportunity. Teams had to assemble complex evidence from scattered sources while new trial results and regulatory decisions continued to change the picture.
We’re building Maven to help teams investigate those opportunities and keep their intelligence current as the market develops. Our team combines biopharma experience with AI engineering. We develop the product with biopharma, consulting, and investment teams whose research questions and workflows shape what we build.
Join the Maven Bio teamBacked by
Y Combinator- Splash Capital
Building in Boston
Our office is in the former B. F. Tweed School in Boston’s Charlestown neighborhood, near Sullivan Square.
Built in 1891 and designed by Boston City Architect Edmund M. Wheelwright, the brick schoolhouse is an early example of Colonial Revival architecture in Charlestown.
24 Cambridge Street, Suite 7Boston, MA 02129
Maven Bio at a glance
- Company name
- Maven Bio
- Legal entity
- RightPage, Inc. (d.b.a. Maven Bio)
- Category
- Live intelligence platform for biopharma
- Founded
- 2023
- Headquarters
- Boston, Massachusetts
- Core offering
- Live intelligence to investigate opportunities, assess material changes, and keep decision materials current
- Customers
- Biopharma teams, life sciences consultants, and investment firms
- Ways to use Maven
- Maven platform, compatible AI assistants through MCP, and monitoring and data API with webhooks
- Team licensing
- Annual licensing with pooled AI credits; allowance and integration scope set out in your quote
- Website
- mavenbio.com
- Company profiles
- LinkedInY Combinator
Frequently asked questions
Can we start with a research question rather than monitoring?
Yes. Start with a research question, an asset screen, or a document review. Add monitoring when you want to follow new developments or keep selected working files current.
Can we use Maven with our existing AI assistant?
Yes. Connect a compatible assistant through Maven’s read-only MCP connector and add reusable research skills in Claude. Your team can also query structured data and retrieve monitoring findings through the API, with webhook notifications when new signals are available.
How can we evaluate Maven for our team?
Bring an asset, market, or recurring deliverable, along with the questions your team needs to answer. We can demonstrate the research and outputs against that brief before scoping a wider evaluation.
Put live intelligence to work for your team.
Bring an opportunity, a strategic question, or an assessment you need to keep current. We’ll discuss the evidence and research your team needs for its next decision.